SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-136680
Filing Date
2024-12-16
Accepted
2024-12-16 16:32:46
Documents
13
Period of Report
2024-12-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crnx-20241216.htm   iXBRL 8-K 59421
2 EX-99.1 crnx-ex99_1.htm EX-99.1 22949
3 GRAPHIC img113038668_0.jpg GRAPHIC 20740
  Complete submission text file 0000950170-24-136680.txt   231269

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20241216.xsd EX-101.SCH 23893
15 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20241216_htm.xml XML 4534
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

IRS No.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38583 | Film No.: 241552299
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)